A targeted NGS panel for overgrowth syndromes, including CDKN1C, DIS3L2, GPC3, NSD1, NFIX, OFD1, EZH2, PTEN, IGF2 and MLPA of the PTEN gene, did not identify any pathogenic variant. This evidence concerns the gene GPC3 and overgrowth syndrome.